针对严重急性营养不良的肠病治疗干预措施调节系统和血管炎症和上皮再生
Jonathan P Sturgeon1, Kuda Mutasa2, Mutsa Bwakura-Dangarembizi3
1Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe; Blizard Institute, Queen Mary University of London, London, UK.
EBioMedicine
|December 11, 2024
概括
针对儿童严重急性营养不良 (SAM) 的新型干预措施显示出有希望的生物标志物结果. 针对肠病的治疗减少了炎症,改善了肠道屏障功能,支持了进一步的临床试验.
科学领域:
- 儿童营养学 儿童营养学
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 严重急性营养不良 (SAM) 是儿童的一种危及生命的疾病,与高死亡率有关.
- 复杂的SAM涉及多系统功能障碍,包括炎症和肠道肠道病变.
- 需要新的干预措施来解决复杂SAM的潜在病理问题.
研究的目的:
- 分析SAM儿童营养不良肠病干预的三级结果.
- 为了评估布塞尼德,N-乙葡萄糖胺,大奶粉和泰杜格鲁胺对生物标志物的影响.
- 探索系统性炎症和肠病标志物之间的关系.
主要方法:
- 在赞比亚和津巴布韦进行的第二阶段多中心试验的分析.
- 122名SAM儿童在14天内接受了四种干预措施之一或标准护理.
- 使用Luminex和ELISA对血样本进行多重生物标记分析,然后进行主要成分分析.
主要成果:
- 布德索尼德和大奶粉减少了全身炎症标志物.
- 大奶粉改善了表皮屏障功能标记物 (GLP2,血管蛋白) 和降低了脂多糖.
- N-乙葡萄糖胺增加了表皮再生和生长因子生物标志物.
结论:
- 对营养不良肠道病的干预表明,对炎症和再生生物标志物有合理的影响.
- 观察到系统性炎症和肠道病变标志物之间的相互依赖.
- 这些发现支持更大规模的试验,以评估复杂SAM儿童的临床益处.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
316
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
316
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
79
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
79
Inflammatory Bowel Disease IV: Pharmacological Management
112
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
112
Inflammatory Bowel Disease V: Surgical Management
118
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
118
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123


